Posted by Michael Wonder on 25 Oct 2022
PHARMAC to consider funding the Meningococcal B vaccine but concerns remain
26 October 2022 - PHARMAC has confirmed it will consider funding the Meningococcal B vaccine, which is a crucial tool in the fight against meningitis.
It comes after an uptick in cases in recent years but advocates said the criteria is too narrow and doesn't go far enough.
